TY - JOUR
T1 - Synthesis and structural characterization of Sr(II) ion-containing octacalcium phosphate incorporated with both 2,6-pyridinedicarboxylate and succinate ions as a bone defect filler with multiple drug loading capability
AU - Kataoka, Takuya
AU - Nishiyama, Seita
AU - Fujii, Eiji
AU - Yoshioka, Tomohiko
AU - Hayakawa, Satoshi
N1 - Publisher Copyright:
© 2024 Elsevier B.V.
PY - 2024/7/20
Y1 - 2024/7/20
N2 - Structural characterization of cation-containing octacalcium phosphate (OCP) samples incorporated with dicarboxylate ions is important to gain insight into their potential as a novel bone defect filler with loading capability of physiologically and pharmacologically active substances. In this study, Sr2+-containing OCP (SrOCPC) samples incorporated with both 2,6-pyridinedicarboxylate (PA) ions and succinate (SA) ions were successfully synthesized. For comparison, OCP samples without Sr2+ (OCPC) were also synthesized. 13C NMR analysis of the dicarboxylate ions in the samples showed that only anionic PA was incorporated in the synthesized samples at PA/(PA+SA) molar ratios above 0.1, whereas both anionic PA and SA were incorporated only at a molar ratio of 0.01. Additionally, the PA content of the SrOCPC and OCPC samples was almost the same at the molar ratio of 0.01. We demonstrated for the first time that the SrOCPC sample at a PA/(PA+SA) molar ratio of 0.01 has the potential to be a novel bone defect filler with multiple drug loading capability of PA, SA, and Sr2+.
AB - Structural characterization of cation-containing octacalcium phosphate (OCP) samples incorporated with dicarboxylate ions is important to gain insight into their potential as a novel bone defect filler with loading capability of physiologically and pharmacologically active substances. In this study, Sr2+-containing OCP (SrOCPC) samples incorporated with both 2,6-pyridinedicarboxylate (PA) ions and succinate (SA) ions were successfully synthesized. For comparison, OCP samples without Sr2+ (OCPC) were also synthesized. 13C NMR analysis of the dicarboxylate ions in the samples showed that only anionic PA was incorporated in the synthesized samples at PA/(PA+SA) molar ratios above 0.1, whereas both anionic PA and SA were incorporated only at a molar ratio of 0.01. Additionally, the PA content of the SrOCPC and OCPC samples was almost the same at the molar ratio of 0.01. We demonstrated for the first time that the SrOCPC sample at a PA/(PA+SA) molar ratio of 0.01 has the potential to be a novel bone defect filler with multiple drug loading capability of PA, SA, and Sr2+.
KW - 2,6-Pyridinedicarboxylate ion
KW - Bone defect filler with drug loading capability
KW - Inorganic/organic composite material
KW - Octacalcium phosphate
KW - Strontium ion
KW - Succinate ion
UR - http://www.scopus.com/inward/record.url?scp=85191163627&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85191163627&partnerID=8YFLogxK
U2 - 10.1016/j.colsurfa.2024.134001
DO - 10.1016/j.colsurfa.2024.134001
M3 - Article
AN - SCOPUS:85191163627
SN - 0927-7757
VL - 693
JO - Colloids and Surfaces A: Physicochemical and Engineering Aspects
JF - Colloids and Surfaces A: Physicochemical and Engineering Aspects
M1 - 134001
ER -